ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer

Juan Wei Wen Gao Cheng Jun Zhu Yi Qian Liu Zhu Mei Ting Cheng; Yong Qian Shu Department of Oncology The First Affiliated Hospital Nanjing Medical University Nanjing Jiangsu P R China
癌症2011-6-15
18阅读
引用收藏
分享

摘要

Studies have shown cell-free microRNA(miRNA) circulating in the serum and plasma with specific expression in cancer,indicating the potential of using miRNAs as biomarkers for cancer diagnosis and therapy.This study was to investigate whether plasma miRNA-21(miR-21) can be used as a biomarker for the early detection of non-small cell lung cancer(NSCLC) and to explore its association with clinicopathologic features and sensitivity to platinum-based chemotherapy.We used real-time RT-PCR to investigate the expression of miR-21 in the plasma of 63 NSCLC patients and 30 healthy controls and correlated the findings with early diagnosis,pathologic parameters,and treatment.Thirty-five patients(stages IIIB and IV) were evaluable for chemotherapeutic responses:11 had partial response(PR);24 had stable and progressive disease(SD+PD).Plasma miR-21 was significantly higher in NSCLC patients than in age-and sex-matched controls(P<0.001).miR-21 was related to TNM stage(P<0.001),but not related to age,sex,smoking status,histological classification,lymph node status,and metastasis(all P>0.05).This marker yielded a receiver operating characteristic(ROC) curve area of 0.775(95% CI:0.681-0.868) with 76.2% sensitivity and 70.0% specificity.Importantly,miR-21 plasma levels in PR samples were several folds lower than that in SD plus PD samples(P=0.049),and were close to that in healthy controls(P=0.130).Plasma miR-21 can serve as a circulating tumor biomarker for the early diagnosis of NSCLC and is related to the sensitivity to platinum-base chemotherapy.

学科与关键词

关键词
Lung neoplasmnon-small cellmiRNA-21biomarkerplasmaearly detectionchemosensitivity
相关
加载中…
  • Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
    Duan, Xiaotong; Qiao, Simiao; Li, Dianhe; Li, Shangbiao; Zheng, Zhihao; Wang, Qin; Zhu, Xiaoxia*Frontiers in Genetics, 2021, 12: 673926.被引 11
  • MicroRNA-21在恶性肿瘤的潜在临床应用进展
    胡桂英; 罗喜平; 孙小丽; 赵春梅; 范保维中华临床医师杂志(电子版), 2013, (05): 2171-2173.
  • Current State of Circulating MicroRNAs as Cancer Biomarkers
    He Yuqing*; Lin Juanjuan; Kong Danli; Huang Mingyuan; Xu Chengkai; Kim Taek Kyun; Etheridge Alton; Luo Yanhong; Ding Yuanlin; Wang KaiClinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine , 2015, 61(9): 1138-1155.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
癌症
发表日期
2011-06-15
卷期
第 06 期
页码
407-414
语言
ENGLISH
成果收录
CHINAJOURNAL
资助标注
supported by grants from the National Natural Science Foundation of China(No.30772549);the Medical Sci-Tech Development Foundation from Health Department of Jiangsu Province(No.P200965)

作者

  • J

    Juan Wei Wen Gao Cheng Jun Zhu Yi Qian Liu Zhu Mei Ting Cheng (第一作者)

  • Y

    Yong Qian Shu Department of Oncology The First Affiliated Hospital Nanjing Medical University Nanjing Jiangsu P R China

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417